loadpatents
name:-0.040390968322754
name:-0.02711009979248
name:-0.0068027973175049
Magnuson; Steven R. Patent Filings

Magnuson; Steven R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Magnuson; Steven R..The latest application filed is for "pyrazolopyrimidine jak inhibitor compounds and methods".

Company Profile
6.30.39
  • Magnuson; Steven R. - Dublin CA
  • Magnuson; Steven R. - South San Francisco CA
  • Magnuson; Steven R. - Wallingford CT
  • Magnuson, Steven R. - Hamden CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyrazolopyrimidine Jak Inhibitor Compounds And Methods
App 20200002345 - Gibbons; Paul ;   et al.
2020-01-02
Therapeutic compounds and uses thereof
Grant 10,308,614 - Albrecht , et al.
2019-06-04
Therapeutic compounds and uses thereof
Grant 10,258,603 - Albrecht , et al.
2019-04-16
Therapeutic compounds and uses thereof
Grant 10,206,931 - Romero , et al. Feb
2019-02-19
Therapeutic compounds and uses thereof
Grant 10,202,378 - Adler , et al. Feb
2019-02-12
Therapeutic compounds and uses thereof
Grant 10,183,009 - Albrecht , et al. Ja
2019-01-22
Therapeutic compounds and uses thereof
Grant 10,150,767 - Albrecht , et al. Dec
2018-12-11
Therapeutic Compounds And Uses Thereof
App 20180086720 - Albrecht; Brian K. ;   et al.
2018-03-29
Therapeutic Compounds And Uses Thereof
App 20180009805 - Adler; Marc ;   et al.
2018-01-11
Aminoquinazoline and pyridopyrimidine derivatives
Grant 9,855,269 - Chen , et al. January 2, 2
2018-01-02
Therapeutic Compounds And Uses Thereof
App 20170342067 - Albrecht; Brian K. ;   et al.
2017-11-30
Therapeutic Compounds And Uses Thereof
App 20170340604 - Albrecht; Brian K. ;   et al.
2017-11-30
Therapeutic Compounds And Uses Thereof
App 20170340605 - Albrecht; Brian K. ;   et al.
2017-11-30
Therapeutic Compounds And Uses Thereof
App 20170312292 - Romero; Anthony F. ;   et al.
2017-11-02
Pyrazolopyrimidine Jak Inhibitor Compounds And Methods
App 20170283424 - Gibbons; Paul ;   et al.
2017-10-05
Aminoquinazoline And Pyridopyrimidine Derivatives
App 20170173026 - Chen; Huifen ;   et al.
2017-06-22
Aminoquinazoline and pyridopyrimidine derivatives
Grant 9,592,235 - Chen , et al. March 14, 2
2017-03-14
Isoquinoline and naphthyridine derivatives
Grant 9,586,956 - Chen , et al. March 7, 2
2017-03-07
Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors
Grant 9,505,767 - Albrecht , et al. November 29, 2
2016-11-29
Triazolopyridine Jak Inhibitor Compounds And Methods
App 20160333011 - Zhu; Bing-Yan ;   et al.
2016-11-17
Aminoquinazoline And Pyridopyrimidine Derivatives
App 20160296525 - Chen; Huifen ;   et al.
2016-10-13
Triazolopyridine JAK inhibitor compounds and methods
Grant 9,434,732 - Zhu , et al. September 6, 2
2016-09-06
Pyrazolopyrimidine Jak Inhibitor Compounds And Methods
App 20160244456 - BLANEY; Jeffrey ;   et al.
2016-08-25
Aminoquinazoline and pyridopyrimidine derivatives
Grant 9,382,241 - Chen , et al. July 5, 2
2016-07-05
Triazolopyridine Jak Inhibitor Compounds And Methods
App 20160024089 - Zhu; Bing-Yan ;   et al.
2016-01-28
Pyrazolopyrimidine Jak Inhibitor Compounds And Methods
App 20150152117 - Gibbons; Paul ;   et al.
2015-06-04
Pyrazolopyrimidine JAK inhibitor compounds and methods
Grant 8,999,998 - Gibbons , et al. April 7, 2
2015-04-07
Triazolopyridine Jak Inhibitor Compounds And Methods
App 20140378449 - Zhu; Bing-Yan ;   et al.
2014-12-25
Isoquinoline And Naphthyridine Derivatives
App 20140343036 - Chen; Huifen ;   et al.
2014-11-20
Triazolopyridine JAK inhibitor compounds and methods
Grant 8,889,673 - Zhu , et al. November 18, 2
2014-11-18
Imidazopyridine Compounds, Compositions And Methods Of Use
App 20140206702 - Lai; Yingjie ;   et al.
2014-07-24
Azabenzothiazole Compounds, Compositions And Methods Of Use
App 20140171408 - Blench; Toby Jonathan ;   et al.
2014-06-19
Pyrazolopyrimidine Jak Inhibitor Compounds And Methods
App 20140107099 - Blaney; Jeffrey ;   et al.
2014-04-17
Azabenzothiazole compounds, compositions and methods of use
Grant 8,697,708 - Blench , et al. April 15, 2
2014-04-15
Triazolopyridine Jak Inhibitor Compounds And Methods
App 20140038939 - Zhu; Bing-Yan ;   et al.
2014-02-06
Pyrazolopyrimidine JAK inhibitor compounds and methods
Grant 8,637,526 - Blaney , et al. January 28, 2
2014-01-28
Triazolopyridine JAK inhibitor compounds and methods
Grant 8,609,687 - Zhu , et al. December 17, 2
2013-12-17
Aminoquinazoline And Pyridopyrimidine Derivatives
App 20130324516 - Chen; Huifen ;   et al.
2013-12-05
Janus kinase inhibitor compounds and methods
Grant 8,486,950 - Goodacre , et al. July 16, 2
2013-07-16
Imidazopyridine Compounds, Compositions And Methods Of Use
App 20130096104 - Lai; Yingjie ;   et al.
2013-04-18
Triazolopyridine Jak Inhibitor Compounds And Methods
App 20120264747 - Zhu; Bing-Yan ;   et al.
2012-10-18
Triazolopyridine Jak Inhibitor Compounds And Methods
App 20120225855 - Zhu; Bing-Yan ;   et al.
2012-09-06
Azabenzothiazole Compounds, Compositions And Methods Of Use
App 20120202788 - Blench; Toby Jonathan ;   et al.
2012-08-09
Pyrazolopyrimidine Jak Inhibitor Compounds And Methods
App 20120190665 - Gibbons; Paul ;   et al.
2012-07-26
Pyrazolopyrimidine Jak Inhibitor Compounds And Methods
App 20120022043 - Blaney; Jeffrey ;   et al.
2012-01-26
Janus Kinase Inhibitor Compounds And Methods
App 20100317643 - GOODACRE; SIMON CHARLES ;   et al.
2010-12-16
Triazolopyridine JAK Inhibitor Compounds and Methods
App 20100048557 - ZHU; Bing-Yan ;   et al.
2010-02-25
Triazolopyridine Jak Inhibitor Compounds And Methods
App 20100035875 - ZHU; Bing-Yan ;   et al.
2010-02-11
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders
Grant 7,109,196 - Wang , et al. September 19, 2
2006-09-19
1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders
App 20060189609 - Wang; Yamin ;   et al.
2006-08-24
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
App 20050215594 - O'Connor, Stephen J. ;   et al.
2005-09-29
2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
Grant 6,919,371 - O'Connor , et al. July 19, 2
2005-07-19
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders
Grant 6,900,205 - Wang , et al. May 31, 2
2005-05-31
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders
App 20040209866 - Wang, Yamin ;   et al.
2004-10-21
Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-.gamma. binding agents
Grant 6,787,651 - Stolle , et al. September 7, 2
2004-09-07
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
App 20040072828 - O'Connor, Stephen J. ;   et al.
2004-04-15
Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists
Grant 6,699,860 - Ladouceur , et al. March 2, 2
2004-03-02
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders
App 20040014751 - Wang, Yamin ;   et al.
2004-01-22
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
Grant 6,660,752 - O'Connor , et al. December 9, 2
2003-12-09
Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents
App 20030087902 - Stolle, Andreas ;   et al.
2003-05-08
Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists
App 20030078258 - Ladouceur, Gaetan H. ;   et al.
2003-04-24
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
App 20030078260 - O'Connor, Stephen J. ;   et al.
2003-04-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed